Explosive hit
Article Abstract:
Perth-based technology hopeful QRSciences Holdings were trading at one-third of its real value according to research report from Sydney-based Aegis Equities Research. The study stated that QRSciences traded from 15 cents to 16 cents despite a valuation sent to shareholders assuring them the stock had a net present value of 44 cent a share.
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Stellar opportunity
Article Abstract:
A broker is offering listed stock at a one-third discount to its net cash backing free of any brokerage charges. The shares prices of Perth based biotech developer, pSivida, has increased from a low of 10 cent last year to a high of 74 cent in the last week of September.
Publication Name: The Bulletin with Newsweek
Subject: News, opinion and commentary
ISSN: 1440-7485
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Gene sweep. Patently promising. Patently obvious
- Abstracts: Bomber command. Exit stage right. PET project
- Abstracts: Risk never sleeps. Consuming passions. Currency crisis
- Abstracts: Shining light. The eyes have it. Break a leg
- Abstracts: National rust. Steak from the heart. A Viennese waltzes into history